Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New horizons for cystic fibrosis treatment.

Pharmacology & therapeutics - 1 Feb 2017

Fajac Isabelle, De Boeck Kris

Abstract excerpt

Cystic fibrosis is an inherited multi-system disease associated with chronic lung infection, malabsorption, salt loss syndromes, male infertility and leading to numerous comorbidities. The landscape in cystic fibrosis care has changed markedly with currently more adult patients than children in many countries. Over 2000 different mutations in the CFTR gene have been reported and the majority are extremely rare....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis
Share to Cell Membrane
Share to Cystic Fibrosis Transmembrane Conductance Regulator

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Design

Share to Gene Editing

Share to Genetic Therapy

Share to Oligonucleotides, Antisense

Share to RNA, Messenger

Source

Identifiers

PMID: 27916649
DOI: 10.1016/j.pharmthera.2016.11.009

Genes

CFTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New horizons for cystic fibrosis treatment.PMID 27916649Read ↗

New horizons in the treatment of cystic fibrosis.Semantic proximity Read ↗

New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls.Semantic proximity Read ↗

Emerging medicines to improve the basic defect in cystic fibrosis.Semantic proximity Read ↗

Progress towards next-generation therapeutics for cystic fibrosis.Semantic proximity Read ↗

Treating the Underlying Cystic Fibrosis Transmembrane Conductance Regulator Defect in Patients with Cystic Fibrosis.Semantic proximity Read ↗

New treatments targeting the basic defects in cystic fibrosis.Semantic proximity Read ↗

Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors.Semantic proximity Read ↗

The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?Semantic proximity Read ↗

Genomically-guided therapies: A new era for cystic fibrosis.Semantic proximity Read ↗

Discovery of CFTR modulators for the treatment of cystic fibrosis.Semantic proximity Read ↗

Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators.Semantic proximity Read ↗

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized MedicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.